HALOZYME THERAPEUTICS INC

Halozyme Therapeutics is trading 0.88 percent higher with a volume of USD 245.9 mn on Friday 30th of October

Halozyme Therapeutics shares climb 18.82% in a month, now at $131.18; explore its biopharma platform and recent 24‑hour market activity.

HALOZYME THERAPEUTICS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Samantha Roth

30/10/2026, 07:04

2 minutes to read

Halozyme Therapeutics is trading 1.89 percent higher with a volume of USD 158.4 mn on Tuesday 27th of October

Halozyme Therapeutics (HALO) climbs 1.9% to $128.46, a $14.4 bn company using recombinant hyaluronidase for diabetes, cancer and drug‑delivery breakthroughs.

HALOZYME THERAPEUTICS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

27/10/2026, 21:15

3 minutes to read